Reading, Pennsylvania
2208 Quarry Dr Suite 200, Reading, PA 19609
Updated Jun 2026
Pennsylvania clinics span from Philadelphia and Pittsburgh to growing telehealth-augmented programs.
13 verified providers, mapped & reviewed.
Showing 13 of 13 clinics
Ranked by quality score (rating × review volume).
Reading, Pennsylvania
2208 Quarry Dr Suite 200, Reading, PA 19609
Updated Jun 2026
Bala Cynwyd, Pennsylvania
191 Presidential Blvd #24, Bala Cynwyd, PA 19004
Updated Jun 2026
Bala Cynwyd, Pennsylvania
146 Montgomery Ave Suite 202, Bala Cynwyd, PA 19004
Updated Jun 2026
Warrington, Pennsylvania
1432 Easton Rd Suite 3i, Warrington, PA 18976
Updated Jun 2026
Philadelphia, Pennsylvania
2418 E York St, Philadelphia, PA 19125
Updated Jun 2026
Philadelphia, Pennsylvania
2401 Pennsylvania Avenue #1C44, Philadelphia, PA 19130
Updated Jun 2026
Avoca, Pennsylvania
824 McAlpine St, Avoca, PA 18641
Updated Jun 2026
Bala Cynwyd, Pennsylvania
1 Bala Ave Unit LL3, Bala Cynwyd, PA 19004
Updated Jun 2026
Monroeville, Pennsylvania
2571 Mosside Blvd #4, Monroeville, PA 15146
Updated Jun 2026
Newtown, Pennsylvania
12 Penns Trail # 101, Newtown, PA 18940
Updated Jun 2026
Pennsylvania State Board of Medicine sets prescribing rules. Spravato may be covered by Highmark, IBC, UPMC Health Plan, and Pennsylvania Medicaid managed-care organizations with prior authorization.
Our directory tracks 13 verified, Google-listed ketamine and Spravato providers across Pennsylvania, updated monthly from public business data.
Spravato (esketamine) is FDA-approved for treatment-resistant depression and is increasingly covered by major insurers in Pennsylvania when REMS protocol criteria are met. IV ketamine remains off-label and is rarely covered.
Most Pennsylvania clinics accept self-referral for IV ketamine, but Spravato typically requires a psychiatrist referral and documented treatment-resistant depression diagnosis.
IV infusions in Pennsylvania generally range $400–$800 per session, with most protocols calling for 6 initial sessions plus periodic boosters. Spravato copays vary by insurance plan.
IV ketamine (racemic) is delivered as an infusion in-clinic and used off-label for depression, PTSD, and chronic pain. Spravato (esketamine) is an FDA-approved intranasal spray for treatment-resistant depression and is covered by REMS — both must be administered in-clinic.